Pharmacist-Driven Deprescribing of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary Disease

Ann Am Thorac Soc. 2021 Apr;18(4):730-733. doi: 10.1513/AnnalsATS.202007-871RL.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / adverse effects
  • Deprescriptions*
  • Humans
  • Pharmacists
  • Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

  • Adrenal Cortex Hormones